Loading clinical trials...
Loading clinical trials...
Determine if frequency specific microcurrent therapy improves pain management of DRA by 30% or greater.
Females aged 18 years or older who are postpartum from a singleton gestation status post vaginal and with diastasis recti will be recruited. The aim of this study is to determine if frequency specific microcurrent therapy improves pain management of DRA by 30% or greater Improving DRA after microcurrent therapy in post-partum females may allow a faster, more effective return to activity thereby improving the return-to-duty transition and establishing personal readiness by meeting military fitness standards.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Mike O'Callaghan Military Medical Center
Nellis Air Force Base, Nevada, United States
Start Date
January 1, 2020
Primary Completion Date
July 7, 2021
Completion Date
July 7, 2021
Last Updated
April 2, 2024
13
ACTUAL participants
INSPIRSTAR IS02 MICROCURRENT STIMULATOR
DEVICE
Lead Sponsor
Diana Trang
NCT07440836
NCT07389993
NCT06286553
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions